23.08.2018
- After two years of trying, Israeli generics producer Teva Pharmaceutical Industries has finally gained approval by the US Food and Drug Administration (FDA) for its copy of Mylan’s...
04.06.2018
- Mylan is leaning on Pfizer to do more to relieve shortages of the EpiPen Auto-Injector. Although the drugmaker based in the US and the UK owns the rights to the EpiPen, which is...
25.08.2017
- Mylan has finalized a $465 million settlement with the US Department of Justice (DoJ) resolving claims relating to its EpiPen emergency allergy treatment. The DoJ’s announcement of...
07.02.2017
- US drugmaker Mylan is facing a probe from the Federal Trade Commission (FTC) as to whether it has violated antitrust laws in protecting its EpiPen from lower-priced competitors...
17.11.2016
- US Senator Chuck Grassley, chairman of the Judiciary Committee, is urging the Department of Justice (DoJ) to reconsider its decision to refuse to appear voluntarily at a Judiciary...
12.10.2016
- Mylan Pharmaceuticals, generics specialist headquartered in both the US and the UK, has paid $465m to the US government to settle claims that it improperly classified its EpiPen...
19.09.2016
- Heather Bresch, head of Mylan Pharmacueticals, will face questions from the US Congress s at a hearing this week focused on sharp price increases for the company's life-saving...
08.09.2016
- The state attorney general's office in New York is conducting a probe into whether Mylan Pharmaceuticals unfairly limited competition for its emergency allergy treatment EpiPen...
